Oncology/Cancer Drugs Market Share Prognosticated Huge Profit by 2020 | Industry Analysis and Forecast Report by Premium Market Insights

Biological drugs based on monoclonal antibodies (mAbs) have emerged as a preferred option for treating various cancer types, especially for blood cancer (leukemia). Rising incidence of various cancer conditions, growing popularity of advance therapies (biological and targeted drug therapies), patents expiration of leading drugs along with commercialization of biosimilars are the few factors driving the growth of global oncology drugs market. However, high cost involved in new drug development coupled with threat of failure and adverse effects associated with cancer drugs therapies would restrain the growth of the market. Commercialization of advanced therapeutics such as targeted and immunotherapies would reduce the negative influence of restraints and fuel the market growth.

Get PDF sample copy: https://www.premiummarketinsights.com/sample/AMR00012632

Companies Covered in this Report are:

Roche diagnostics,
Novartis AG,
Celgene Corporation,
AstraZeneca,
Johnson & Johnson,
Merck & Co.,
Eli Lilly & Co.
GlaxoSmithKline

The global oncology drugs market is expected to reach at $111.9 billion by 2020. Patent expiration of key cancer drugs such as Herceptin, Erbitux, Rituxan and Avastin, is expected to boost the growth of cancer biosimilars market by 2020. Going further, the biological therapies are expected to dominate the market by 2020, due to their high efficacy, target specific action and less toxicity. Blood cancer drugs market was the largest revenue generating segment in 2013 owing to the high cost of drugs (immunotherapies) used for the treatment of blood cancer.

Geographically, North America, dominates the market followed by Europe. North America accounted for about ~38% share in the overall oncology drugs market in 2013 owing to the heavy investments by multinational companies in research and development of cancer drugs, particularly immune therapeutics, favorable reimbursement policies, and high adoption rate of immunotherapies. On the other hand, Asia-Pacific market would grow at the promising CAGR of 8.7% during the forecast period. Such high growth rate is majorly due to increasing awareness towards advanced therapies namely immunotherapies and increase in per capita healthcare spending.

Companies operating in the cancer drugs market focus on several strategies such as collaboration, approval and acquisition.

KEY BENEFITS
The report provides the quantitative analysis of the current market and estimations through 2013-2020 that assists in identifying the prevailing market opportunities to capitalize on
The report helps in understanding the strategies adopted by various companies for gaining market share in the cancer drugs market
The report provides comprehensive analysis of factors that drive and restrict the growth of the cancer drugs market
Market conditions of cancer drugs market across all geographic regions are comprehensively analyzed
Competitive intelligence (of leading manufacturers) helps in understanding the competitive scenario across the geographies
SWOT analysis of the key market players is provided to illustrate the business strategies adopted by the companies

To Purchase This report details at: https://www.premiummarketinsights.com/buy/AMR00012632

MARKET SEGMENTATION

The cancer drugs market is segmented by the therapeutic modalities, cancer types and geography.

MARKET BY THERAPEUTIC MODALITIES
Chemotherapy
Targeted Therapy
Immunotherapy (Biologic Therapy)
Hormonal Therapy
Others

MARKET BY CANCER TYPES
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers

MARKET BY GEOGRAPHY
North America
United States
Canada
Mexico
Europe
Germany
France
United Kingdom
Others
Asia-Pacific
India
China
Japan
Australia
Others
LAMEA
GCC (Gulf Corporation Council)
Others

About Premium Market Insights:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.

Contact Us:
Name: Sameer Joshi
Organization: Premium Market Insights
Email: [email protected]
Phone: +1-646-491-9876

Posted by on Thursday June 20 2019, 11:18 AM EDT. All trademarks acknowledged. Filed under Biotechnology, Business Services, Diagnostics, Featured Press Release, Healthcare, Life Sciences, Medical Devices, Pharmaceuticals. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

News Categories

Featured Press Releases

Log in